Role of oxygen in cancer: Looking beyond hypoxia

Anti-Cancer Agents in Medicinal Chemistry

Volumn 9, Issue 5, 2009, Pages 517-525

  López Lázaro, Miguel ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Carcinogenesis; Cell proliferation; Glycolysis; HIF 1; Hydrogen peroxide; Metastasis; Reactive oxygen species; Tumor growth

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; REACTIVE OXYGEN METABOLITE;

ALTITUDE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; GENE ACTIVATION; GENE EXPRESSION; GLYCOLYSIS; HUMAN; HYPOXIA; METABOLISM; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; OXYGEN METABOLISM; OXYGENATION; REVIEW; TRANSCRIPTION INITIATION; TUMOR GROWTH; TUMOR LOCALIZATION;

EID: 67651083751     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152009788451806     Document Type: Review

References (110)

1. Vogelstein, B.; Kinzler, K.W. Cancer genes and the pathways they control. Nat. Med., 2004, 10(8), 789-799.
2. Folkman, J.; Hahnfeldt, P.; Hlatky, L. Cancer: looking outside the genome Nat. Rev. Mol. Cell Biol., 2000, 1(1), 76-79.
3. Semenza, G.L. Hypoxia and cancer. Cancer Metastasis Rev., 2007, 26(2), 223-224.
4. Zhong, H.; De Marzo, A.M.; Laughner, E.; Lim, M.; Hilton, D.A.; Zagzag, D.; Buechler, P.; Isaacs, W.B.; Semenza, G.L.; Simons, J.W. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res., 1999, 59(22), 5830-5835.
5. Semenza, G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer, 2003, 3(10), 721-732.
6. Vaupel, P.; Harrison, L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist, 2004, 9(5), 4-9.
7. Vaupel, P.; Mayer, A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev., 2007, 26(2), 225-239.
8. Vaupel, P.; Hockel, M.; Mayer, A. Detection and characterization of tumor hypoxia using pO2 histography. Antioxid. Redox. Signal., 2007, 9(8), 1221-1235.
9. Semenza, G.L. Life with oxygen. Science, 2007, 318(5847), 62-64.
10. Semenza, G.L. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov. Today, 2007, 12(19-20), 853-859.
11. Semenza, G.L. Development of novel therapeutic strategies that target HIF-1. Expert. Opin. Ther. Targets, 2006, 10(2), 267-280.
12. Lopez-Lazaro, M. Hypoxia-inducible factor 1 as a possible target for cancer chemoprevention. Cancer Epidemiol. Biomarkers Prev., 2006, 15(12), 2332-2335.
13. Chan, D.A.; Giaccia, A.J. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev., 2007, 26(2), 333-339.
14. Gort, E.H.; Groot, A.J.; van der, W.E.; van Diest, P.J.; Vooijs, M.A. Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr. Mol. Med., 2008, 8(1), 60-67.
15. Jiang, B.H.; Semenza, G.L.; Bauer, C.; Marti, H.H. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am. J Physiol., 1996, 271(4), C1172-C1180.
16. Gruber, G.; Greiner, R.H.; Hlushchuk, R.; Aebersold, D.M.; Altermatt, H.J.; Berclaz, G.; Djonov, V. Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? Breast Cancer Res., 2004, 6(3), R191-R198.
17. Hutchison, G.J.; Valentine, H.R.; Loncaster, J.A.; Davidson, S.E.; Hunter, R.D.; Roberts, S.A.; Harris, A.L.; Stratford, I.J.; Price, P.M.; West, C.M. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix. Clin. Cancer Res., 2004, 10(24), 8405-8412.
18. Mayer, A.; Wree, A.; Hockel, M.; Leo, C.; Pilch, H.; Vaupel, P. Lack of correlation between expression of HIF-1alpha protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix. Cancer Res., 2004, 64(16), 5876-5881.
19. Mayer, A.; Hockel, M.; Wree, A.; Vaupel, P. Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers. Clin. Cancer Res., 2005, 11(7), 2768-2773.
20. Mayer, A.; Hockel, M.; Vaupel, P. Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally advanced cancers of the uterine cervix. Clin. Cancer Res., 2005, 11(20), 7220-7225.
21. Mayer, A.; Hockel, M.; Vaupel, P. Endogenous hypoxia markers: case not proven. Adv. Exp. Med. Biol., 2008, 614(4), 127-136.
22. Zhong, H.; Mabjeesh, N.; Willard, M.; Simons, J. Nuclear expression of hypoxia-inducible factor 1alpha protein is heterogeneous in human malignant cells under normoxic conditions. Cancer Lett., 2002, 181(2), 233-238.
23. Haddad, J.J.; Land, S.C. A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. FEBS Lett., 2001, 505(2), 269-274.
24. Lu, H.; Forbes, R.A.; Verma, A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J. Biol. Chem., 2002, 277(26), 23111-23115.
25. Isaacs, J.S.; Jung, Y.J.; Mole, D.R.; Lee, S.; Torres-Cabala, C.; Chung, Y.L.; Merino, M.; Trepel, J.; Zbar, B.; Toro, J.; Ratcliffe, P.J.; Linehan, W.M.; Neckers, L. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell, 2005, 8(2), 143-153.
26. Gerald, D.; Berra, E.; Frapart, Y.M.; Chan, D.A.; Giaccia, A.J.; Mansuy, D.; Pouyssegur, J.; Yaniv, M.; Mechta-Grigoriou, F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell, 2004, 118(6), 781-794.
27. Dalgard, C.L.; Lu, H.; Mohyeldin, A.; Verma, A. Endogenous 2-oxoacids differentially regulate expression of oxygen sensors. Biochem. J., 2004, 380(2), 419-424.
28. Lu, H.; Dalgard, C.; Mohyeldin, A.; McFate, T.; Tait, A.S.; Verma, A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem., 2005, 280(51), 41928-41939.
29. Selak, M.A.; Armour, S.M.; MacKenzie, E.D.; Boulahbel, H.; Watson, D.G.; Mansfield, K.D.; Pan, Y.; Simon, M.C.; Thompson, C.B.; Gottlieb, E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell, 2005, 7(1), 77-85.
30. Knowles, H.J.; Mole, D.R.; Ratcliffe, P.J.; Harris, A.L. Normoxic stabilization of hypoxia-inducible factor-1alpha by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1. Cancer Res., 2006, 66(5), 2600-2607.
31. Szatrowski, T.P.; Nathan, C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res., 1991, 51(3), 794-798.
32. Lopez-Lazaro, M. Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapy. Cancer Lett., 2007, 252(1), 1-8.
33. Gatenby, R.A.; Gillies, R.J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer, 2004, 4(11), 891-899.
34. Lopez-Lazaro, M. The Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? Anticancer Agents Med. Chem., 2008, 8(3), 305-312.
35. Brahimi-Horn, M.C.; Pouyssegur, J. Oxygen, a source of life and stress. FEBS Lett., 2007, 581(19), 3582-3591.
36. Rajendran, J.G.; Mankoff, D.A.; O'Sullivan, F.; Peterson, L.M.; Schwartz, D.L.; Conrad, E.U.; Spence, A.M.; Muzi, M.; Farwell, D.G.; Krohn, K.A. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin. Cancer Res., 2004, 10(7), 2245-2252.
37. Cherk, M.H.; Foo, S.S.; Poon, A.M.; Knight, S.R.; Murone, C.; Papenfuss, A.T.; Sachinidis, J.I.; Saunder, T.H.; O'Keefe, G.J.; Scott, A.M. Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET. J. Nucl. Med., 2006, 47(12), 1921-1926.
38. Lopez-Lazaro, M. Does hypoxia really control tumor growth? Cell Oncol., 2006, 28(5-6), 327-329.
39. Deberardinis, R.J.; Sayed, N.; Ditsworth, D.; Thompson, C.B. Brick by brick: metabolism and tumor cell growth. Curr. Opin. Genet. Dev., 2008, 18(1), 54-61.
40. Deberardinis, R.J.; Lum, J.J.; Hatzivassiliou, G.; Thompson, C.B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab., 2008, 7(1), 11-20.
41. Evans, S.M.; Hahn, S.M.; Magarelli, D.P.; Koch, C.J. Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation. Am. J. Clin. Oncol., 2001, 24(5), 467-472.
42. Peacock, A.J. ABC of oxygen: oxygen at high altitude. BMJ, 1998, 317(7165), 1063-1066.
43. Eckhoff, N.D.; Shultis, J.K.; Clack, R.W.; Ramer, E.R. Correlation of leukemia mortality rates with altitude in the United States. Health Phys., 1974, 27(4), 377-380.
44. Burton, A.C. Cancer and altitude. Does intracellular pH regulate cell division? Eur. J. Cancer, 1975, 11(5), 365-371.
45. Amsel, J.; Waterbor, J.W.; Oler, J.; Rosenwaike, I.; Marshall, K. Relationship of site-specific cancer mortality rates to altitude. Carcinogenesis, 1982, 3(5), 461-465.
46. Droge, W. Free radicals in the physiological control of cell function. Physiol. Rev., 2002, 82(1), 47-95.
47. Finkel, T. Radical medicine: treating ageing to cure disease. Nat. Rev. Mol. Cell Biol., 2005, 6(12), 971-976.
48. Kovacic, P.; Jacintho, J.D. Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr. Med. Chem., 2001, 8(7), 773-796.
49. Cerutti, P.A. Prooxidant states and tumor promotion. Science, 1985, 227(4685), 375-381.
50. Toyokuni, S.; Okamoto, K.; Yodoi, J.; Hiai, H. Persistent oxidative stress in cancer. FEBS Lett., 1995, 358(1), 1-3.
51. Hussain, S.P.; Hofseth, L.J.; Harris, C.C. Radical causes of cancer. Nat. Rev. Cancer, 2003, 3(4), 276-285.
52. Klaunig, J.E.; Kamendulis, L.M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 2004, 44, 239-267.
53. Valko, M.; Rhodes, C.J.; Moncol, J.; Izakovic, M.; Mazur, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact., 2006, 160(1), 1-40.
54. Lopez-Lazaro, M. Excessive superoxide anion generation plays a key role in carcinogenesis. Int. J. Cancer, 2007, 120(6), 1378-1380.
55. Halliwell, B. Oxidative stress and cancer: have we moved forward? Biochem. J., 2007, 401(1), 1-11.
56. Finkel, T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol., 2003, 15(2), 247-254.
57. Ahotupa, M.; Bussacchini-Griot, V.; Bereziat, J.C.; Camus, A.M.; Bartsch, H. Rapid oxidative stress induced by N-nitrosamines. Biochem. Biophys. Res. Commun., 1987, 146(3), 1047-1054.
58. Kopnin, P.B.; Kravchenko, I.V.; Furalyov, V.A.; Pylev, L.N.; Kopnin, B.P. Cell type-specific effects of asbestos on intracellular ROS levels, DNA oxidation and G1 cell cycle checkpoint. Oncogene, 2004, 23(54), 8834-8840.
59. Chou, W.C.; Jie, C.; Kenedy, A.A.; Jones, R.J.; Trush, M.A.; Dang, C.V. Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc. Natl. Acad. Sci. USA, 2004, 101(13), 4578-4583.
60. O'Donovan, P.; Perrett, C.M.; Zhang, X.; Montaner, B.; Xu, Y.Z.; Harwood, C.A.; McGregor, J.M.; Walker, S.L.; Hanaoka, F.; Karran, P. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science, 2005, 309(5742), 1871-1874.
61. Phillipson, R.P.; Tobi, S.E.; Morris, J.A.; McMillan, T.J. UV-A induces persistent genomic instability in human keratinocytes through an oxidative stress mechanism. Free Radic. Biol. Med., 2002, 32(5), 474-480.
62. Gong, G.; Waris, G.; Tanveer, R.; Siddiqui, A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl. Acad. Sci. USA, 2001, 98(17), 9599-9604.
63. Hsieh, Y.H.; Su, I.J.; Wang, H.C.; Chang, W.W.; Lei, H.Y.; Lai, M.D.; Chang, W.T.; Huang, W. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis, 2004, 25(10), 2023-2032.
64. Yan, T.; Oberley, L.W.; Zhong, W.; St Clair, D.K. Manganese-containing superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts. Cancer Res., 1996, 56(12), 2864-2871.
65. Lassoued, S.; Ben Ameur, R.; Ayadi, W.; Gargouri, B.; Ben Mansour, R.; Attia, H. Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. Mol. Cell Biochem., 2008, 313(1-2), 179-186.
66. Naito, Y.; Yoshikawa, T. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic. Biol. Med., 2002, 33(3), 323-336.
67. Petersen, D.R. Alcohol, iron-associated oxidative stress, and cancer. Alcohol, 2005, 35(3), 243-249.
68. Reinke, L.A. Spin trapping evidence for alcohol-associated oxidative stress. Free Radic. Biol. Med., 2002, 32(10), 953-957.
69. Muscat, J.E.; Kleinman, W.; Colosimo, S.; Muir, A.; Lazarus, P.; Park, J.; Richie, J.P., Jr. Enhanced protein glutathiolation and oxidative stress in cigarette smokers. Free Radic. Biol. Med., 2004, 36(4), 464-470.
70. Kosecik, M.; Erel, O.; Sevinc, E.; Selek, S. Increased oxidative stress in children exposed to passive smoking. Int. J. Cardiol., 2005, 100(1), 61-64.
71. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest., 2004, 114(12), 1752-1761.
72. Yang, S.; Zhu, H.; Li, Y.; Lin, H.; Gabrielson, K.; Trush, M.A.; Diehl, A.M. Mitochondrial adaptations to obesity-related oxidant stress. Arch. Biochem. Biophys., 2000, 378(2), 259-268.
73. DePinho, R.A. The age of cancer. Nature, 2000, 408(6809), 248-254.
74. Sohal, R.S.; Weindruch, R. Oxidative stress, caloric restriction, and aging. Science, 1996, 273(5271), 59-63.
75. Schriner, S.E.; Linford, N.J.; Martin, G.M.; Treuting, P.; Ogburn, C.E.; Emond, M.; Coskun, P.E.; Ladiges, W.; Wolf, N.; Van Remmen, H.; Wallace, D.C.; Rabinovitch, P.S. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science, 2005, 308(5730), 1909-1911.
76. Warburg, O. On the origin of cancer cells. Science, 1956, 123(3191), 309-314.
77. Cuezva, J.M.; Krajewska, M.; de Heredia, M.L.; Krajewski, S.; Santamaria, G.; Kim, H.; Zapata, J.M.; Marusawa, H.; Chamorro, M.; Reed, J.C. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res., 2002, 62(22), 6674-6681.
78. Isidoro, A.; Martinez, M.; Fernandez, P.L.; Ortega, A.D.; Santamaria, G.; Chamorro, M.; Reed, J.C.; Cuezva, J.M. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem. J., 2004, 378(1), 17-20.
79. Matoba, S.; Kang, J.G.; Patino, W.D.; Wragg, A.; Boehm, M.; Gavrilova, O.; Hurley, P.J.; Bunz, F.; Hwang, P.M. p53 regulates mitochondrial respiration. Science, 2006, 312(5780), 1650-1653.
80. Chen, Z.; Lu, W.; Garcia-Prieto, C.; Huang, P. The Warburg effect and its cancer therapeutic implications. J. Bioenerg. Biomembr., 2007, 39(3), 267-274.
81. Lopez-Lazaro, M. HIF-1: Hypoxia-inducible factor or dysoxia-inducible factor? FASEB J., 2006, 20(5), 828-832.
82. Lopez-Lazaro, M. Why do tumors metastasize? Cancer Biol. Ther., 2007, 6(2), 141-144.
83. Chandel, N.S.; McClintock, D.S.; Feliciano, C.E.; Wood, T.M.; Melendez, J.A.; Rodriguez, A.M.; Schumacker, P.T. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J. Biol. Chem., 2000, 275(33), 25130-25138.
84. Brunelle, J.K.; Bell, E.L.; Quesada, N.M.; Vercauteren, K.; Tiranti, V.; Zeviani, M.; Scarpulla, R.C.; Chandel, N.S. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab., 2005, 1(6), 409-414.
85. Guzy, R.D.; Hoyos, B.; Robin, E.; Chen, H.; Liu, L.; Mansfield, K.D.; Simon, M.C.; Hammerling, U.; Schumacker, P.T. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab., 2005, 1(6), 401-408.
86. Mansfield, K.D.; Guzy, R.D.; Pan, Y.; Young, R.M.; Cash, T.P.; Schumacker, P.T.; Simon, M.C. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab., 2005, 1(6), 393-399.
87. Bell, E.L.; Chandel, N.S. Mitochondrial oxygen sensing: regulation of hypoxia-inducible factor by mitochondrial generated reactive oxygen species. Essays Biochem., 2007, 43, 17-27.
88. Nelson, K.K.; Ranganathan, A.C.; Mansouri, J.; Rodriguez, A.M.; Providence, K.M.; Rutter, J.L.; Pumiglia, K.; Bennett, J.A.; Melendez, J.A. Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin. Cancer Res., 2003, 9(1), 424-432.
89. Nishikawa, M.; Tamada, A.; Hyoudou, K.; Umeyama, Y.; Takahashi, Y.; Kobayashi, Y.; Kumai, H.; Ishida, E.; Staud, F.; Yabe, Y.; Takakura, Y.; Yamashita, F.; Hashida, M. Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clin. Exp. Metastasis., 2004, 21(3), 213-221.
90. Hyoudou, K.; Nishikawa, M.; Umeyama, Y.; Kobayashi, Y.; Yamashita, F.; Hashida, M. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells. Clin. Cancer Res., 2004, 10(22), 7685-7691.
91. Hyoudou, K.; Nishikawa, M.; Kobayashi, Y.; Umeyama, Y.; Yamashita, F.; Hashida, M. PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal. Free Radic. Biol. Med., 2006, 41(9), 1449-1458.
92. Nishikawa, M.; Hashida, M. Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes. Expert. Opin. Drug Deliv., 2006, 3(3), 355-369.
93. Jackson, A.L.; Loeb, L.A. Microsatellite instability induced by hydrogen peroxide in Escherichia coli. Mutat. Res., 2000, 447(2), 187-198.
94. Park, S.; You, X.; Imlay, J.A. Substantial DNA damage from sub-micromolar intracellular hydrogen peroxide detected in Hpx- mutants of Escherichia coli. Proc. Natl. Acad. Sci. USA, 2005, 102(26), 9317-9322.
95. Arnold, R.S.; Shi, J.; Murad, E.; Whalen, A.M.; Sun, C.Q.; Polavarapu, R.; Parthasarathy, S.; Petros, J.A.; Lambeth, J.D. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc. Natl. Acad. Sci. USA, 2001, 98(10), 5550-5555.
96. Suh, Y.A.; Arnold, R.S.; Lassegue, B.; Shi, J.; Xu, X.; Sorescu, D.; Chung, A.B.; Griendling, K.K.; Lambeth, J.D. Cell transformation by the superoxide-generating oxidase Mox1. Nature, 1999, 401(6748), 79-82.
97. Okamoto, M.; Kawai, K.; Reznikoff, C.A.; Oyasu, R. Transformation in vitro of a nontumorigenic rat urothelial cell line by hydrogen peroxide. Cancer Res., 1996, 56(20), 4649-4653.
98. Okamoto, M.; Reddy, J.K.; Oyasu, R. Tumorigenic conversion of a non-tumorigenic rat urothelial cell line by overexpression of H2O2-generating peroxisomal fatty acyl-CoA oxidase. Int. J. Cancer, 1997, 70(6), 716-721.
99. Kundu, M.; Thompson, C.B. Autophagy: basic principles and relevance to disease. Annu. Rev. Pathol., 2008, 3, 427-455.
100. Levine, B.; Kroemer, G. Autophagy in the pathogenesis of disease. Cell, 2008, 132(1), 27-42.
101. Mizushima, N.; Levine, B.; Cuervo, A.M.; Klionsky, D.J. Autophagy fights disease through cellular self-digestion. Nature, 2008, 451(7182), 1069-1075.
102. Gatenby, R.A.; Gawlinski, E.T.; Gmitro, A.F.; Kaylor, B.; Gillies, R.J. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res., 2006, 66(10), 5216-5223.
103. Brahimi-Horn, M.C.; Pouyssegur, J. Hypoxia in cancer cell metabolism and pH regulation. Essays Biochem., 2007, 43, 165-178.
104. Bertout, J.A.; Patel, S.A.; Simon, M.C. The impact of O2 availability on human cancer. Nat. Rev. Cancer, 2008, 8(12), 967-975.
105. Brown, J.M.; Wilson, W.R. Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer, 2004, 4(6), 437-447.
106. Chen, Q.; Espey, M.G.; Krishna, M.C.; Mitchell, J.B.; Corpe, C.P.; Buettner, G.R.; Shacter, E.; Levine, M. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a prodrug to deliver hydrogen peroxide to tissues. Proc. Natl. Acad. Sci. USA, 2005, 102(38), 13604-13609.
107. Pelicano, H.; Martin, D.S.; Xu, R.H.; Huang, P. Glycolysis inhibition for anticancer treatment. Oncogene, 2006, 25(34), 4633-4646.
108. Lopez-Lazaro, M. Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved. Expert. Opin. Ther. Targets, 2007, 11(8), 1043-1053.
109. Schofield, C.J.; Ratcliffe, P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol., 2004, 5(5), 343-354.
110. Coleman, M.L.; Ratcliffe, P.J. Oxygen sensing and hypoxia-induced responses. Essays Biochem., 2007, 43, 1-15.